Advancing IO: Clinical Updates in Personalized Cancer Vaccines & PD-1/VEGF

Thu, Mar 18 | 09:20 AM - 09:40 AM

General Session

Speaker:

Shweta Jain VP, Head of Early Development, Oncology Clinical Development Merck

Industry Specific Content:

Science & Clinical Development

Track:

General Session